Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Maintains disciplined, low-turnover exposure to dominant global compounders across artificial intelligence, enterprise software, and digital infrastructure while opportunistically adding to core holdings on valuation dislocations.
Full Quick Take
Maintains disciplined, low-turnover exposure to dominant global compounders across artificial intelligence, enterprise software, and digital infrastructure while opportunistically adding to core holdings on valuation dislocations.
Narrowly trailing its benchmark, while selectively adding to healthcare holdings on price weakness. The portfolio remains anchored in high-quality compounders trading at an estimated 43% discount to intrinsic value.
Full Quick Take
Narrowly trailing its benchmark, while selectively adding to healthcare holdings on price weakness. The portfolio remains anchored in high-quality compounders trading at an estimated 43% discount to intrinsic value.